Replies to post #9892 on Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

That drug ponatinib was best in class but adverse side effect developed which necessitated that boxed warning. They developed another best in class drug called Brigatinib which was also approved. But management was running low on cash so they sold it. The hedge guy who took over that company when it was floundering because of cash problem came in at a cost basis of 4 and change. His name is Alex Denner.